Enhancement of anticancer potential of polyphenols by covalent modifications

Biochemical Pharmacology

Volumn 109, Issue , 2016, Pages 1-13

  Lewandowska, Urszula ^a   Fichna, Jakub ^a   Gorlach, Sylwia ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Anticancer drug; Carcinogenesis; Chemoprevention; Derivative; Polyphenol

Indexed keywords

POLYPHENOL; ANTINEOPLASTIC AGENT; TUMOR PROTEIN;

ACYLATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CELL PROLIFERATION; CHEMICAL MODIFICATION; CHEMICAL REACTION; DRUG CYTOTOXICITY; GALLOYLATION; HUMAN; HYDROXYLATION; METASTASIS; METHYLATION; PRIORITY JOURNAL; TUMOR GROWTH; ACETYLATION; ANIMAL; CELL CYCLE CHECKPOINT; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; STRUCTURE ACTIVITY RELATION;

ACETYLATION; ACYLATION; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXYLATION; METHYLATION; NEOPLASM PROTEINS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; POLYPHENOLS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84955311418     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2015.12.019     Document Type: Review

References (95)

1. L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal Global cancer statistics, 2012 CA Cancer J. Clin. 65 2015 87 108 10.3322/caac.21262
2. C.L. Sun, J.M. Yuan, W.P. Koh, and M.C. Yu Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies Carcinogenesis 27 2006 1301 1309 10.1093/carcin/bgl024
3. A. Ui, S. Kuriyama, M. Kakizaki, T. Sone, N. Nakaya, K. Ohmori-Matsuda, and et al. Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study Cancer Causes Control 20 2009 1939 1945 10.1007/s10552-009-9388-x
4. Y. Wu, L. Zhang, R. Na, J. Xu, Z. Xiong, N. Zhang, and et al. Plasma genistein and risk of prostate cancer in Chinese population Int. Urol. Nephrol. 47 2015 965 970 10.1007/s11255-015-0981-5
5. W.Y. Huang, Y.Z. Cai, and Y. Zhang Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention Nutr. Cancer 62 2010 1 20 10.1080/01635580903191585
6. S. Gorlach, J. Fichna, and U. Lewandowska Polyphenols as mitochondria-targeted anticancer drugs Cancer Lett. 366 2015 141 149 10.1016/j.canlet.2015.07.004
7. A. Crozier, I.B. Jaganath, and M.N. Clifford Dietary phenolics: chemistry, bioavailability and effects on health Nat. Prod. Rep. 26 2009 1001 1043 10.1039/b802662a
8. H. Halbwirth The creation and physiological relevance of divergent hydroxylation patterns in the flavonoid pathway Int. J. Mol. Sci. 11 2010 595 621 10.3390/ijms11020595
9. F. Danesi, P.A. Kroon, S. Saha, D. Biase, L.F. D'Antuono, and A. Bordoni Mixed pro- and anti-oxidative effects of pomegranate polyphenols in cultured cells Int. J. Mol. Sci. 15 2014 19458 19471 10.3390/ijms151119458
10. S.R. Hsieh, W.C. Cheng, Y.M. Su, C.H. Chiu, and Y.M. Liou Molecular targets for anti-oxidative protection of green tea polyphenols against myocardial ischemic injury Biomedicine (Taipei) 4 2014 7 16 10.7603/s40681-014-0023-0
11. U. Lewandowska, K. Szewczyk, K. Owczarek, Z. Hrabec, A. Podsȩdek, M. Koziołkiewicz, and et al. Flavanols from Japanese quince (Chaenomeles japonica) fruit inhibit human prostate and breast cancer cell line invasiveness and cause favorable changes in Bax/Bcl-2 mRNA ratio Nutr. Cancer 65 2013 273 285 10.1080/01635581.2013.749292
12. Z. Shu, M. Yu, G. Zeng, X. Zhang, L. Wu, and X. Tan Epigallocatechin-3-gallate inhibits proliferation of human aortic smooth muscle cells via up-regulating expression of mitofusin 2 Eur. J. Cell Biol. 93 2014 137 144 10.1016/j.ejcb.2014.04.001
13. S. Gorlach, W. Wagner, A. Podsȩdek, K. Szewczyk, M. Koziołkiewicz, and J. Dastych Procyanidins from Japanese quince (Chaenomeles japonica) fruit induce apoptosis in human colon cancer Caco-2 cells in a degree of polymerization-dependent manner Nutr. Cancer 63 2011 1348 1360 10.1080/01635581.2011.608480
14. U. Lewandowska, K. Szewczyk, K. Owczarek, Z. Hrabec, A. Podsȩdek, M. Koziołkiewicz, and et al. Flavanols from evening primrose (Oenothera paradoxa) defatted seeds inhibit prostate cells invasiveness and cause changes in Bcl-2/Bax mRNA ratio J. Agric. Food Chem. 61 2013 2987 2998 10.1021/jf304269x
15. U. Lewandowska, K. Szewczyk, K. Owczarek, Z. Hrabec, A. Podsȩdek, D. Sosnowska, and et al. Procyanidins from evening primrose (Oenothera paradoxa) defatted seeds inhibit invasiveness of breast cancer cells and modulate the expression of selected genes involved in angiogenesis, metastasis, and apoptosis Nutr. Cancer 65 2013 1219 1231 10.1080/01635581.2013.830314
16. L. Duluc, C. Jacques, R. Soleti, R. Andriantsitohaina, and G. Simard Delphinidin inhibits VEGF induced-mitochondrial biogenesis and Akt activation in endothelial cells Int. J. Biochem. Cell Biol. 53 2014 9 14 10.1016/j.biocel.2014.03.030
17. M. Sałaga, U. Lewandowska, D. Sosnowska, P.K. Zakrzewski, A.I. Cygankiewicz, A. Piechota-Polańczyk, and et al. Polyphenol extract from evening primrose pomace alleviates experimental colitis after intracolonic and oral administration in mice Naunyn Schmiedebergs Arch. Pharmacol. 387 2014 1069 1078 10.1007/s00210-014-1025-x
18. M. Zielińska, U. Lewandowska, A. Podsȩdek, A.I. Cygankiewicz, D. Jacenik, M. Sałaga, and et al. Orally available extract from Brassica oleracea var. capitata rubra attenuates experimental colitis in mouse models of inflammatory bowel diseases J. Funct. Foods 17 2015 587 599 10.1111/jphp.12335
19. E.L. Symonds, I. Konczak, and M. Fenech The Australian fruit Illawarra plum (Podocarpus elatus Endl., Podocarpaceae) inhibits telomerase, increases histone deacetylase activity and decreases proliferation of colon cancer cells Br. J. Nutr. 109 2013 2117 2125 10.1017/S0007114512004333
20. S. Kuntz, S. Rudloff, H. Asseburg, C. Borsch, B. Fröhling, F. Unger, and et al. Uptake and bioavailability of anthocyanins and phenolic acids from grape/blueberry juice and smoothie in vitro and in vivo Br. J. Nutr. 113 2015 1044 1055 10.1017/S0007114515000161
21. M.D. Pandareesh, R.B. Mythri, and M.M. Srinivas Bharath Bioavailability of dietary polyphenols: factors contributing to their clinical application in CNS diseases Neurochem. Int. 89 2015 198 208 10.1016/j.neuint.2015.07.003
22. U. Lewandowska, K. Szewczyk, E. Hrabec, A. Janecka, and S. Gorlach Overview of metabolism and bioavailability enhancement of polyphenols J. Agric. Food Chem. 61 2013 12183 12199 10.1021/jf404439b
23. M. Gao, C. Chen, A. Fan, J. Zhang, D. Kong, Wang, and et al. Covalent and non-covalent curcumin loading in acid-responsive polymeric micellar nanocarriers Nanotechnology 26 2015 275101 10.1088/0957-4484/26/27/275101
24. M. Murias, W. Jäger, N. Handler, T. Erker, Z. Horvath, T. Szekeres, and et al. Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship Biochem. Pharmacol. 69 2005 903 912 10.1016/j.bcp.2004.12.001
25. Z. Horvath, M. Murias, P. Saiko, T. Erker, N. Handler, S. Madlener, and et al. Cytotoxic and biochemical effects of 3,3′,4,4′,5,5′-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells Exp. Hematol. 34 2006 1377 1384 10.1016/j.exphem.2006.05.018
26. M. Fontecave, M. Lepoivre, E. Elleingand, C. Gerez, and O. Guittet Resveratrol, a remarkable inhibitor of ribonucleotide reductase FEBS Lett. 421 1998 277 279 10.1016/S0014-5793(97)01572-X
27. V. Paulitschke, N. Schicher, T. Szekeres, W. Jäger, L. Elbling, A.B. Riemer, and et al. 3,3′,4,4′,5,5′-Hexahydroxystilbene impairs melanoma progression in a metastatic mouse model J. Invest. Dermatol. 130 2010 1668 1679 10.1038/jid.2009.376
28. J. Mikuła-Pietrasik, A. Kuczmarska, M. Kucińska, M. Murias, M. Wierzchowski, M. Winckiewicz, and et al. Resveratrol and its synthetic derivatives exert opposite effects on mesothelial cell-dependent angiogenesis via modulating secretion of VEGF and IL-8/CXCL8 Angiogenesis 15 2012 361 376 10.1007/s10456-012-9266-0
29. M. Kucinska, H. Piotrowska, M.W. Luczak, J. Mikula-Pietrasik, K. Ksiazek, M. Wozniak, and et al. Effects of hydroxylated resveratrol analogs on oxidative stress and cancer cells death in human acute T cell leukemia cell line: prooxidative potential of hydroxylated resveratrol analogs Chem. Biol. Interact. 209 2014 96 110 10.1016/j.cbi.2013.12.009
30. G. Pani, R. Colavitti, B. Bedogni, S. Fusco, D. Ferraro, S. Borrello, and et al. Mitochondrial superoxide dismutase: a promising target for new anticancer therapies Curr. Med. Chem. 11 2004 1299 1308 10.2174/0929867043365297
31. J. Mikuła-Pietrasik, P. Sosińska, M. Murias, M. Wierzchowski, M. Brewińska-Olchowik, K. Piwocka, and et al. High potency of a novel resveratrol derivative, 3,3′,4,4′-tetrahydroxy-trans-stilbene, against ovarian cancer is associated with an oxidative stress-mediated imbalance between DNA damage accumulation and repair Oxid. Med. Cell Longev. 2015 1 15 135691 10.1155/2015/135691
32. M. Tolomeo, S. Grimaudo, A. Di Cristina, M. Roberti, D. Pizzirani, M. Meli, and et al. Pterostilbene and 3′-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells Int. J. Biochem. Cell Biol. 37 2005 1709 1726 10.1016/j.biocel.2005.03.004
33. T.C. Cheng, C.S. Lai, M.C. Chung, N. Kalyanam, M. Majeed, C.T. Ho, and et al. Potent anti-cancer effect of 3′-hydroxypterostilbene in human colon xenograft tumors PLoS One 9 2014 10.1371/journal.pone.0111814.eCollection 2014 111814
34. T. Walle, N. Ta, T. Kawamori, X. Wen, P.A. Tsuji, and U.K. Walle Cancer chemopreventive properties of orally bioavailable flavonoids - methylated versus unmethylated flavones Biochem. Pharmacol. 73 2007 1288 1296 10.1016/j.bcp.2006.12.028
35. N. Ta, and T. Walle Aromatase inhibition by bioavailable methylated flavones J. Steroid Biochem. Mol. Biol. 107 2007 127 129 10.1016/j.jsbmb.2007.01.006
36. S.E. Bulun, Z. Lin, G. Imir, S. Amin, M. Demura, B. Yilmaz, and et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment Pharmacol. Rev. 57 2005 359 383 10.1124/pr.57.3.6
37. X. Wen, and T. Walle Methylated flavonoids have greatly improved intestinal absorption and metabolic stability Drug Metab. Dispos. 34 2006 1786 1792 10.1124/dmd.106.011122
38. C. Tamvakopoulos, K. Dimas, Z.D. Sofianos, S. Hatziantoniou, Z. Han, Z.L. Liu, and et al. Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin Clin. Cancer Res. 13 2007 1269 1277 10.1158/1078-0432.CCR-06-1839
39. Y. Bader, S. Madlener, S. Strasser, S. Maier, P. Saiko, N. Stark, and et al. Stilbene analogues affect cell cycle progression and apoptosis independently of each other in an MCF-7 array of clones with distinct genetic and chemoresistant backgrounds Oncol. Rep. 19 2008 801 810 10.3892/or.19.3.801
40. H. Yamashita, M. Nishio, T. Toyama, H. Sugiura, Z. Zhang, S. Kobayashi, and et al. Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer Breast Cancer Res. 6 2004 24 30 10.1186/bcr738
41. D.J. Slamon, G.M. Clark, S.G. Wong, W.J. Levin, A. Ullrich, and W.L. McGuire Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 1987 177 182 10.1126/science.3798106
42. H. Cai, M. Al-Fayez, R.G. Tunstall, S. Platton, P. Greaves, W.P. Steward, and et al. The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in ApcMin mice Mol. Cancer Ther. 4 2005 1288 1292 10.1158/1535-7163.MCT-05-0165
43. H. Cai, S. Sale, R. Schmid, R.G. Britton, K. Brown, W.P. Steward, and et al. Flavones as colorectal cancer chemopreventive agents - phenol-o-methylation enhances efficacy Cancer Prev. Res. (Phila) 2 2009 743 750 10.1158/1940-6207.CAPR-09-0081
44. P.M. Borralho, A.E. Simões, S.E. Gomes, R.T. Lima, T. Carvalho, and et al. MiR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation PLoS One 6 2011 10.1371/journal.pone.0023787 23787
45. F. Cianci, C. Cortesini, P. Bechi, O. Fantappie, L. Messerini, A. Vannacci, and et al. Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer Gastroenterology 121 2001 1339 1347 10.1053/gast.2001.29691
46. B. Xiong, T.J. Sun, W.D. Hu, F.L. Cheng, M. Mao, and Y.F. Zhou Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance World J. Gastroenterol. 11 2005 1105 1108 10.3748/wjg.v11.i8.1105
47. A.W. Wu, J. Gu, Z.F. Li, J.F. Ji, and G.W. Xu COX-2 expression and tumor angiogenesis in colorectal cancer World J. Gastroenterol. 10 2004 2323 2326 10.7150/ijms.4173
48. Z. Horvath, S. Marihart-Fazekas, P. Saiko, M. Grusch, M. Ozsüy, M. Harik, and et al. Novel resveratrol derivatives induce apoptosis and cause cell cycle arrest in prostate cancer cell lines Anticancer Res. 27 2007 3459 3464 PMID: 17970095
49. P. Saiko, M. Pemberger, Z. Horvath, I. Savinc, M. Grusch, N. Handler, and et al. Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: inhibition of ribonucleotide reductase activity Oncol. Rep. 19 2008 1621 1626 10.3892/or.19.6.1621
50. W.H. Lam, A. Kazi, D.J. Kuhn, L.M. Chow, A.S. Chan, Q.P. Dou, and et al. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG] Bioorg. Med. Chem. 12 2004 5587 5593 10.1016/j.bmc.2004.08.002
51. W.K. Wu, K.M. Sakamoto, M. Milani, G. Aldana-Masankgay, D. Fan, K. Wu, and et al. Macroauto-phagy modulates cellular response to proteasome inhibitors in cancer therapy Drug Resist. Updat. 13 2010 87 92 10.1016/j.drup.2010.04.003
52. A.V. Sorokin, E.R. Kim, and L.P. Ovchinnikov Proteasome system of protein degradation and processing Biochemistry 74 2009 1411 1442 10.1134/S000629790913001X
53. K.R. Landis-Piwowar, C. Huo, D. Chen, V. Milacic, G. Shi, T.H. Chan, and et al. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent Cancer Res. 67 2007 4303 4310 10.1158/0008-5472.CAN-06-4699
54. N.M. Patel, S. Nozaki, N.H. Shortle, P. Bhat-Nakshatri, T.R. Newton, S. Rice, and et al. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by Ikappa B alpha super-repressor and parthenolide Oncogene 19 2000 4159 4169 10.1038/sj.onc.1203768
55. A. Oeckinghaus, M.S. Hayden, and S. Ghosh Crosstalk in NF-kappaB signaling pathways Nat. Immunol. 12 2011 695 708 10.1038/ni.2065
56. M.B. Møller P27 in cell cycle control and cancer Leuk. Lymphoma 39 2000 19 27 10.3109/10428190009053535
57. S.Y. Sun Chemopreventive agent-induced modulation of death receptors Apoptosis 10 2005 1203 1210 10.1007/s10495-005-2274-4
58. S.L. Oei, and M. Ziegler ATP for the DNA ligation step in base excision repair is generated from poly(ADP-ribose) J. Biol. Chem. 275 2000 23234 23239 PMID: 10930429
59. J.D. Lambert, S. Sang, J. Hong, S.J. Kwon, M.J. Lee, C.T. Ho, and et al. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate Drug Metab. Dispos. 34 2006 2111 2116 10.1124/dmd.106.011460
60. S. Moncada, and A.E. Higgs The l-arginine-nitric oxide pathway N. Engl. J. Med. 329 1993 2002 2012 10.1056/NEJM199312303292706
61. J. Beckman Biochemistry of nitric oxide and peroxynitrite P. Kubes, Nitric Oxide: A Modulator of Cell-Cell Interactions in the Microcirculation 1995 R.G. Landes Company Austin, Texas, USA 1 18
62. K.D. Kröncke, K. Fehsel, and V. Kolb-Bachofen Nitric oxide: cytotoxicity versus cytoprotection - how, why, when, and where? Nitric Oxide 1 1997 107 120 10.1006/niox.1997.0118
63. U. Pohl, and C. de Vitt A unique role of NO in the control of blood flow News Physiol. Sci. 14 1999 74 80 PMID: 11390824
64. D. Salvemini Regulation of cyclooxygenase enzymes by nitric oxide Cell. Moll. Life Sci. 53 1997 576 582 10.1007/s000180050074
65. R.A. Gupta, and R.N. DuBois Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 Nat. Rev. Cancer 1 2001 11 21 10.1038/35094017
66. R. Masunga, H. Kohno, D.K. Dhar, S. Ohno, M. Shibakita, S. Kinugasa, and et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients Clin. Cancer Res. 6 2000 4064 4068 PMID: 11051257
67. A.W. Wu, J. Gu, Z.F. Li, J.F. Ji, and G.W. Xu COX-2 expression and tumor angiogenesis in colorectal cancer World J. Gastroenterol. 10 2004 2323 2326 PMID: 15285012
68. L.J. McCawley, and L.M. Matrisian Matrix metalloproteinases: multifunctional contributors to tumor progression Mol. Med. Today 6 2000 149 156 10.1016/S1357-4310(00)01686-5
69. S.C. Lee, W.K. Chan, T.W. Lee, W.H. Lam, X. Wang, T.H. Chan, and et al. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo Nutr. Cancer 60 2008 483 491 10.1080/01635580801947674
70. Y.S. Chiou, N.J. Ma, S. Sang, C.T. Ho, Y.J. Wang, and M.H. Pan Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice J. Agric. Food Chem. 60 2012 3441 3451 10.1021/jf300441p
71. M. Serafini, I. Peluso, and A. Raguzzini Flavonoids as anti-inflammatory agents Proc. Nutr. Soc. 69 2010 273 278 10.1017/S002966511000162X
72. + skin stem cells and skin tumors Carcinogenesis 34 2013 1315 1322 10.1093/carcin/bgt042
73. S. Okamoto, S. Ishihara, T. Okamoto, S. Doi, K. Harui, Y. Higashino, and et al. Inhibitory activity of synthesized acetylated Procyanidin B1 analogs against HeLa S3 cells proliferation Molecules 19 2014 1775 1785 10.3390/molecules19021775
74. K. Ahmed, Z.L. Wei, Q.L. Zhao, N. Nakajima, T. Matsunaga, M. Ogasawara, and et al. Role of fatty acid chain length on the induction of apoptosis by newly synthesized catechin derivatives Chem. Biol. Interact. 185 2010 182 188 10.1016/j.cbi.2010.02.045
75. Y. Mizushina, A. Saito, K. Horikawa, N. Nakajima, A. Tanaka, H. Yoshida, and et al. Acylated catechin derivatives: inhibitors of DNA polymerase and angiogenesis Front. Biosci. (Elite Ed) 3 2011 1337 1348 PMID: 21622140
76. L. Actis-Goretta, L.J. Romanczyk, C.A. Rodriguez, C. Kwik-Uribe, and C.L. Keen Cytotoxic effects of digalloyl dimer procyanidins in human cancer cell lines J. Nutr. Biochem. 19 2008 797 808 10.1016/j.jnutbio.2007.10.004
77. A. Bernhaus, M. Fritzer-Szekeres, M. Grusch, P. Saiko, G. Krupitza, S. Venkateswarlu, and et al. Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells Cancer Lett. 274 2009 299 304 10.1016/j.canlet.2008.09.020
78. P. Noordhuis, U. Holwerda, C.L. Van der Wilt, C.J. Van Groeningen, K. Smid, S. Meijer, and et al. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers Ann. Oncol. 15 2004 1025 1032 10.1093/annonc/mdh264
79. P. Saiko, G. Graser, B. Giessrigl, M.T. Steinmann, H. Schuster, A. Lackner, and et al. Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells Invest. New Drugs 31 2013 1115 1124 10.1007/s10637-013-0009-x
80. A. Constantinou, and A. Husband Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex Anticancer Res. 22 2002 2581 2585 PMID: 12529967
81. J.C. Wang Cellular roles of DNA topoisomerases: a molecular perspective Nat. Rev. Mol. Cell Biol. 3 2002 430 440 10.1038/nrm831
82. T.K. Choueiri, R. Wesolowski, and T.M. Mekhail Phenoxodiol: isoflavone analog with antineoplastic activity Curr. Oncol. Rep. 8 2006 104 107 10.1007/s11912-006-0044-2
83. M.G. Kelly, G. Mor, A. Husband, D.M. O'Malley, L. Baker, M. Azodi, and et al. Phase II evaluation of phenoxodiol in combination with cisplatin or paclitaxel in women with platinum/taxane-refractory/resistant epithelial ovarian, fallopian tube, or primary peritoneal cancers Int. J. Gynecol. Cancer 21 2011 633 639 10.1097/IGC.0b013e3182126f05
84. S. Mahoney, F. Arfuso, M. Millward, and A. Dharmarajan The effects of phenoxodiol on the cell cycle of prostate cancer cell lines Cancer Cell Int. 14 2014 110 10.1186/s12935-014-0110-z
85. K. Polkowski, J. Popiołkiewicz, P. Krzeczyński, J. Ramza, W. Pucko, O. Zegrocka-Stendel, and et al. Cytostatic and cytotoxic activity of synthetic genistein glycosides against human cancer cell lines Cancer Lett. 203 2004 59 69 10.1016/j.canlet.2003.08.023
86. L. Sánchez-del-Campo, F. Otón, A. Tárraga, J. Cabezas-Herrera, S. Chazarra, and J.N. Rodríguez-López Synthesis and biological activity of a 3,4,5-trimethoxybenzoyl ester analogue of epicatechin-3-gallate J. Med. Chem. 51 2008 2018 2026 10.1021/jm701346h
87. Z. Herceg Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors Mutagenesis 22 2007 91 103 10.1093/mutage/gel065
88. I.T. Johnson, and N.J. Belshaw Environment, diet and CpG island methylation: epigenetic signals in gastrointestinal neoplasia Food Chem. Toxicol. 46 2008 1346 1359 10.1016/j.fct.2007.09.101
89. S. Piyaviriyakul, K. Shimizu, T. Asakawa, T. Kan, P. Siripong, and N. Oku Anti-angiogenic activity and intracellular distribution of epigallocatechin-3-gallate analogs Biol. Pharm. Bull. 34 2011 396 400 10.1248/bpb.34.396
90. S. Padhye, H. Yang, A. Jamadar, Q.C. Cui, D. Chavan, K. Dominiak, and et al. New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells Pharm. Res. 26 2009 1874 1880 10.1007/s11095-009-9900-8
91. S. Ali, A. Ahmad, S. Banerjee, S. Padhye, K. Dominiak, J.M. Schaffert, and et al. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF Cancer Res. 70 2010 3606 3617 10.1158/0008-5472.CAN-09-4598
92. S.N. Zhang, L. Zhang, G.C. Sun, X.B. Chen, and G.Z. Zhou A synthetic curcumin derivative hydrazinobenzoylcurcumin induces autophagy in A549 lung cancer cells Pharm. Biol. 52 2014 111 116 10.3109/13880209.2013.816971
93. G.Z. Zhou, S.L. Xu, G.C. Sun, and X.B. Chen Novel curcumin analogue IHCH exhibits potent anti-proliferative effects by inducing autophagy in A549 lung cancer cells Mol. Med. Rep. 10 2014 441 446 10.3892/mmr.2014.2183
94. G.Z. Zhou, G.C. Sun, and S.N. Zhang The interplay between autophagy and apoptosis induced by one synthetic curcumin derivative hydrazinobenzoylcurcumin in A549 lung cancer cells J. Biochem. Mol. Toxicol. 29 2015 267 273 10.1002/jbt.21694
95. A.S. Alva, S.H. Gultekin, and E.H. Baehrecke Autophagy in human tumors: cell survival or death? Cell Death Differ. 11 2004 1046 1048 10.1038/sj.cdd.4401445